NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $336,491 | +1.0% | 3,303 | 0.0% | 0.15% | +0.7% |
Q2 2023 | $333,306 | +9.7% | 3,303 | 0.0% | 0.15% | +5.5% |
Q1 2023 | $303,876 | +4.6% | 3,303 | +3.1% | 0.14% | -3.3% |
Q4 2022 | $290,576 | +19.6% | 3,203 | 0.0% | 0.15% | +5.6% |
Q3 2022 | $243,000 | -7.3% | 3,203 | +3.2% | 0.14% | -3.4% |
Q2 2022 | $262,000 | -4.4% | 3,103 | -0.7% | 0.15% | 0.0% |
Q1 2022 | $274,000 | +0.4% | 3,126 | 0.0% | 0.15% | 0.0% |
Q4 2021 | $273,000 | +6.6% | 3,126 | 0.0% | 0.15% | 0.0% |
Q3 2021 | $256,000 | -6.2% | 3,126 | +4.3% | 0.15% | -11.4% |
Q2 2021 | $273,000 | +18.7% | 2,996 | +11.1% | 0.17% | +12.2% |
Q1 2021 | $230,000 | -34.5% | 2,696 | -27.5% | 0.15% | -31.2% |
Q4 2020 | $351,000 | +12.1% | 3,719 | +3.3% | 0.22% | +0.5% |
Q3 2020 | $313,000 | +17.2% | 3,601 | +17.4% | 0.21% | +4.9% |
Q2 2020 | $267,000 | -1.8% | 3,066 | +6.5% | 0.20% | +0.5% |
Q4 2019 | $272,000 | – | 2,879 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |